Zlatuse Kristkova
Brno, JM, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Journal: British journal of haematology
Published: December 29, 2022
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry.
Journal: Rheumatology international
Published: October 27, 2021
Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA.
Journal: Therapeutic advances in musculoskeletal disease
Published: October 12, 2021
Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry.
Journal: Arthritis research & therapy
Published: September 11, 2020
Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.
Journal: Expert opinion on biological therapy
Published: November 19, 2019
First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter.
Journal: Leukemia research
Published: January 06, 2019
Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry.
Journal: Clinical and experimental rheumatology
Published: August 20, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026